Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen
Annalisa Ruggeri,
Myriam Labopin,
Maria Pia Sormani,
Guillermo Sanz,
Jaime Sanz,
Fernanda Volt,
Gerard Michel,
Franco Locatelli,
Cristina Diaz De Heredia,
Tracey O’Brien,
William Arcese,
Anna Paola Iori,
Sergi Querol,
Gesine Kogler,
Lucilla Lecchi,
Fabienne Pouthier,
Federico Garnier,
Cristina Navarrete,
Etienne Baudoux,
Juliana Fernandes,
Chantal Kenzey,
Mary Eapen,
Eliane Gluckman,
Vanderson Rocha,
Riccardo Saccardi
Affiliations
Annalisa Ruggeri
Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, France;Hospital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, AP-HP, UPMC University of Paris 06, UMR-S 938, CEREST-TC EBMT, France;Cord Blood Committee EBMT, University of Genova, Italy
Myriam Labopin
Hospital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, AP-HP, UPMC University of Paris 06, UMR-S 938, CEREST-TC EBMT, France
Maria Pia Sormani
Biostatistics Unit, Department of Health Sciences (DISSAL), University of Genova, Italy
Guillermo Sanz
Hospital Universitario y Politécnico La Fe, Valencia, Spain
Jaime Sanz
Hospital Universitario y Politécnico La Fe, Valencia, Spain
Fernanda Volt
Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, France
Gerard Michel
Hôpital d’Enfants de la Timone, Marseille, France
Franco Locatelli
Dipartimento di Oncoematologia Pediatrica, Ospedale Bambino Gesù, IRCSS, Rome/University of Pavia, Italy
Cristina Diaz De Heredia
Servicio de Hematologia y Oncologia Pediátricas, Hospital Universitario Vall d’Hebron, Barcelona, Spain
Tracey O’Brien
Sydney Children’s Hospital, Sydney, Australia
William Arcese
Rome Transplant Network, University Tor Vergata, Rome, Italy
Anna Paola Iori
Università La Sapienza, Dip. Biotecnologie Cellulari ed Ematologia, Rome, Italy
Sergi Querol
Barcelona Cord Blood Bank, Barcelona, Spain
Gesine Kogler
Dusseldorf Cord Blood Bank, University of Dusseldorf, Germany
Lucilla Lecchi
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Fabienne Pouthier
Besançon Cord Blood Bank of the Etablissement Français du Sang, Besançon, France
Federico Garnier
Agence de la Biomedecine, Paris, France
Cristina Navarrete
NHS-Cord Blood Bank, NHSBT, Colindale Ave, and University College London, UK
Etienne Baudoux
Liege Cord Blood Bank, University of Liege, Belgium
Juliana Fernandes
Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, France
Chantal Kenzey
Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, France
Mary Eapen
Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Eliane Gluckman
Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, France;Monacord, Centre Scientifique de Monaco, Monaco
Vanderson Rocha
Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, France;Churchill Hospital, Oxford University Hospitals, UK
Riccardo Saccardi
Eurocord, Hospital Saint Louis, AP-HP, and IUH University Paris VII, France;Careggi University Hospital, Florence, Italy
Umbilical cord blood transplant recipients are exposed to an increased risk of graft failure, a complication leading to a higher rate of transplant-related mortality. The decision and timing to offer a second transplant after graft failure is challenging. With the aim of addressing this issue, we analyzed engraftment kinetics and outcomes of 1268 patients (73% children) with acute leukemia (64% acute lymphoblastic leukemia, 36% acute myeloid leukemia) in remission who underwent single-unit umbilical cord blood transplantation after a myeloablative conditioning regimen. The median follow-up was 31 months. The overall survival rate at 3 years was 47%; the 100-day cumulative incidence of transplant-related mortality was 16%. Longer time to engraftment was associated with increased transplant-related mortality and shorter overall survival. The cumulative incidence of neutrophil engraftment at day 60 was 86%, while the median time to achieve engraftment was 24 days. Probability density analysis showed that the likelihood of engraftment after umbilical cord blood transplantation increased after day 10, peaked on day 21 and slowly decreased to 21% by day 31. Beyond day 31, the probability of engraftment dropped rapidly, and the residual probability of engrafting after day 42 was 5%. Graft failure was reported in 166 patients, and 66 of them received a second graft (allogeneic, n=45). Rescue actions, such as the search for another graft, should be considered starting after day 21. A diagnosis of graft failure can be established in patients who have not achieved neutrophil recovery by day 42. Moreover, subsequent transplants should not be postponed after day 42.